2026 NPPES data Ophthalmology Physician NPI 1699732750 MD
Verify on CMS →

CYNTHIA TARKANIAN, MD

Ophthalmology Physician in ARVADA, Colorado. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
806
Medicare Part D claims · 236 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$19.75
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

CYNTHIA TARKANIAN, MD filed 806 Medicare Part D claims in 2023 as a Ophthalmology Physician in ARVADA, Colorado, prescribing 67% generic.

806
Part D claims, 2023
67%
generic prescribing
$19.75
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

CYNTHIA TARKANIAN, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

806 Top 27% higher than 73% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

CYNTHIA TARKANIAN, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about CYNTHIA TARKANIAN, MD?

Quality data not reported

NPI registry status

Active

Issued 05/01/2006

NPI 1699732750

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

806 43% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

Specialty distribution in Colorado

How Ophthalmology Physician compares to other specialties among Colorado providers

Colorado providers

Ophthalmology Physician share within Colorado

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Colorado

Specialty board-certification context

Estimated specialty board-certified rate — Ophthalmology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Ophthalmology Physician ABMS/AOA estimate

Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Ophthalmology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

CYNTHIA TARKANIAN, MD appears in the CMS NPPES registry as a Ophthalmology Physician provider holding MD credentials at 7950 KIPLING ST, ARVADA, CO, 80005, with a listed phone of (303) 422-2305. NPI 1699732750 was issued on 05/01/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TARKANIAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 806 prescription claims written by this provider, covering 236 Medicare beneficiaries and totaling roughly $127K in drug spend, split 33% brand-name and 67% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

7950 KIPLING ST
ARVADA, CO 80005

Provider Details

NPI 1699732750
Specialty Ophthalmology Physician
Credentials MD
Gender Female
NPI Issued 05/01/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for CYNTHIA TARKANIAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$20

Largest payer

Bausch & Lomb Americas Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

CYNTHIA TARKANIAN, MD — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 806 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

806
Total Claims
$127K
Total Drug Cost
236
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,743
Total Day Supply
49,835
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$102K
Generic Drug Cost
$25K

Patient Demographics

Average Patient Age
78.5 years
Avg HCC Risk Score
1.31
Gender Split
63% female / 37% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What CYNTHIA TARKANIAN, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
255
Timolol Maleate
166
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
52
Tobramycin-Dexamethasone
Tobramycin/Dexamethasone
46
Lumigan
Bimatoprost
44
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
39
Restasis
Cyclosporine
30
Fluorometholone
24
Prednisolone Acetate
16
Erythromycin
Erythromycin Base
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How CYNTHIA TARKANIAN, MD fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

CYNTHIA TARKANIAN, MD's 806 claims are below the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Colorado

Other clinicians with the same primary specialty enrolled in Colorado, drawn from the same CMS NPPES roster as TARKANIAN.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is CYNTHIA TARKANIAN, MD's specialty?
CYNTHIA TARKANIAN, MD specializes in Ophthalmology Physician and practices in ARVADA, Colorado. Credentials: MD.
How much does CYNTHIA TARKANIAN, MD prescribe under Medicare Part D?
In 2023, CYNTHIA TARKANIAN, MD wrote 806 Medicare Part D claims totaling $127K in drug costs for 236 beneficiaries.
Where is CYNTHIA TARKANIAN, MD located?
CYNTHIA TARKANIAN, MD is located at 7950 KIPLING ST, ARVADA, CO, 80005. Phone: (303) 422-2305.
What is CYNTHIA TARKANIAN, MD's NPI number?
CYNTHIA TARKANIAN, MD's National Provider Identifier (NPI) is 1699732750, issued on 05/01/2006.
Does CYNTHIA TARKANIAN, MD prescribe more brand-name or generic drugs?
CYNTHIA TARKANIAN, MD's prescribing is 33% brand-name and 67% generic drugs by claim count, with $102K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does CYNTHIA TARKANIAN, MD prescribe most often?
Based on 2023 Medicare Part D data, CYNTHIA TARKANIAN, MD's most frequently prescribed drugs include Latanoprost, Timolol Maleate, Neomycin-Polymyxin-Dexameth. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does CYNTHIA TARKANIAN, MD accept Medicare?
CYNTHIA TARKANIAN, MD appears in CMS Medicare data with 806 Part D claims and 236 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify CYNTHIA TARKANIAN, MD's credentials?
CYNTHIA TARKANIAN, MD's NPI is 1699732750 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology